Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1762621

BARDOXOLONE METHYL
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2

Basic Information

ChEMBL ID CHEMBL1762621
Name BARDOXOLONE METHYL
Phase Phase III
Structure Type MOL
InChI Key WPTTVJLTNAWYAO-KPOXMGGZSA-N

Known Names

Bardoxolone methyl Bardoxolone methyl ester CDDO-Me CDDO-METHYL ESTER NSC 713200 NSC-713200 RTA 402 Rta-402 RTA402
32
Targets
55
Activities
2
Assay Types
5
PK Parameters
20
Publications
9
Known Names
12
Indications
3
Mechanisms

Molecular Properties

505.7
MW (Da)
6.38
ALogP
5
HBA
0
HBD
84.2
PSA (Ų)
0.39
QED
2
Ro5 Violations
1
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer

Flags

Natural Product
USAN Stem -olone
USAN Year 2008

Extended Properties

Molecular Formula C32H43NO4
MW 505.70
Aromatic Rings 0
Heavy Atoms 37
NP-Likeness 2.23

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Peroxisome proliferator-activated receptor gamma antagonist ANTAGONIST Peroxisome proliferator-activated receptor gamma
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor INHIBITOR Inhibitor of nuclear factor kappa-B kinase subunit beta
Keap1/Nrf2 inhibitor INHIBITOR Keap1/Nrf2

Indications

Diabetic Nephropathies Hypertension, Pulmonary Hypertension, Pulmonary Polycystic Kidney, Autosomal Dominant Melanoma Nephritis, Hereditary Renal Insufficiency, Chronic Severe Acute Respiratory Syndrome Hematologic Neoplasms Liver Diseases Neoplasms Pancreatic Neoplasms

Activity Summary

IC50 50 meas. best 10.0
EC50 5 meas. best 8.06

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Mus musculus
CHEMBL375
IC50 10.0 9.9867 0.1 3
NON-PROTEIN TARGET
CHEMBL3879801
IC50 9.7 6.9425 0.2 4
HCT-116
CHEMBL394
IC50 9.6 7.84 0.2 2
Unchecked
CHEMBL612545
EC50 8.06 8.06 8.7 1
Ghrelin O-acyltransferase
CHEMBL1255134
IC50 7.46 7.46 35.0 1
MCF7
CHEMBL387
IC50 7.3 6.4375 50.0 4
Nuclear factor erythroid 2-related factor 2
CHEMBL1075094
EC50 7.22 7.22 60.0 1
SARS-CoV-2
CHEMBL4303835
EC50 6.7 6.62 200.0 2
HepG2
CHEMBL395
IC50 6.58 6.115 260.0 4
HT-29
CHEMBL384
IC50 6.55 6.55 280.0 1
HCT-8
CHEMBL613510
IC50 6.54 6.54 290.0 1
ADMET
CHEMBL612558
IC50 6.5 6.175 316.0 2
A549
CHEMBL392
IC50 6.44 6.15 360.0 4
Unchecked
CHEMBL612545
IC50 6.42 6.0067 377.4 3
L02
CHEMBL4296457
IC50 6.4 6.4 400.0 1
GES1
CHEMBL4296415
IC50 6.4 6.4 400.0 1
BGC-823
CHEMBL614526
IC50 6.3 6.3 500.0 2
MDA-MB-231
CHEMBL400
IC50 6.25 6.25 560.0 1
SGC-7901
CHEMBL614909
IC50 6.22 6.22 600.0 1
HOS
CHEMBL614736
IC50 6.18 6.18 660.0 1
U2OS
CHEMBL615023
IC50 6.13 6.13 740.0 1
NCI-N87
CHEMBL614197
IC50 6.1 6.1 800.0 1
MCF-10A
CHEMBL614321
IC50 6.1 6.1 800.0 1
MGC-803
CHEMBL3706566
IC50 6.05 6.05 900.0 1
A549/TR
CHEMBL4483226
IC50 5.77 5.77 1703.0 1
HEK293
CHEMBL614818
IC50 5.66 5.66 2200.0 1
Signal transducer and activator of transcription 3
CHEMBL4026
IC50 5.62 5.62 2380.0 1
RAW264.7
CHEMBL612557
IC50 5.4 5.4 4000.0 1
HT-29
CHEMBL384
EC50 5.36 5.36 4340.0 1
H9c2
CHEMBL614576
IC50 5.28 5.28 5200.0 1
Replicase polyprotein 1ab
CHEMBL4523582
IC50 5.24 5.24 5810.0 1
Ghrelin O-acyltransferase
CHEMBL3588729
IC50 5.22 4.93 6000.0 2
Ubiquitin carboxyl-terminal hydrolase 7
CHEMBL2157850
IC50 4.85 4.85 14080.0 1
Ubiquitin carboxyl-terminal hydrolase 2
CHEMBL1293227
IC50 4.66 4.66 22000.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 2179.2 ng.hr.mL-1 Rattus norvegicus
AUC 2057.2 ng.hr.mL-1 Rattus norvegicus
CL 78.05 mL.min-1.kg-1 Rattus norvegicus
Cmax 9920.9 nM Rattus norvegicus
T1/2 4.413 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Mus musculus IC50 = 0.1 nM 10.0 Inhibitory activity against production of nitric oxide induced by interferon-gam... 10617085
Mus musculus IC50 = 0.1 nM 10.0 Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamm... 11063620
Mus musculus IC50 = 0.11 nM 9.96 Inhibitory activity against production of nitric oxide induced by interferon gam... 11909709
NON-PROTEIN TARGET IC50 = 0.2 nM 9.7 Antiinflammatory activity in CD-1 mouse Macrophage assessed as inhibition of IFN... 21361338
HCT-116 IC50 = 0.25 nM 9.6 Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay 30429953
Unchecked EC50 = 8.71 nM 8.06 Activation of Keap1/Cul3/Nrf2 in human BEAS2B cells assessed as increase in NQO1... 30626555
Ghrelin O-acyltransferase IC50 = 35.0 nM 7.46 Inhibition of mouse GOAT expressed in HEK293FT cells co-expressing pre-proghreli... -
MCF7 IC50 = 50.0 nM 7.3 Inhibitory concentration against proliferation of MCF-7 (ER Positive) breast can... 15369396
Nuclear factor erythroid 2-related factor 2 EC50 = 60.0 nM 7.22 Activation of Nrf2 (unknown origin) expressed in human HaCaT-ARE-luc cells after... 28753294
SARS-CoV-2 EC50 = 200.0 nM 6.7 Antiviral activity against SARS-CoV-2 infected in human Calu-3 cells assessed as... 37659195
HepG2 IC50 = 260.0 nM 6.58 Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... 31051401
HT-29 IC50 = 280.0 nM 6.55 Antiproliferative activity against human HT-29 cells after 72 hrs by SRB assay 30429953
SARS-CoV-2 EC50 = 290.0 nM 6.54 Antiviral activity against SARS-CoV-2 infected in African green monkey Vero cell... 37659195
HCT-8 IC50 = 290.0 nM 6.54 Antiproliferative activity against human HCT8 cells after 72 hrs by SRB assay 30429953
ADMET IC50 = 316.0 nM 6.5 Antiproliferative activity against human CCD-841-CoN cells assessed as inhibitio... 25675144
MCF7 IC50 = 350.0 nM 6.46 Cytotoxicity against human MCF7 cells assessed as reduction in cell viability in... 31051401
A549 IC50 = 360.0 nM 6.44 Cytotoxicity against human A549 cells assessed as reduction in cell viability in... 31051401
NON-PROTEIN TARGET IC50 = 363.0 nM 6.44 Antiproliferative activity against 5-FU resistant human HCT8 cells assessed as i... 25675144
Unchecked IC50 = 377.4 nM 6.42 Inhibition of Pseudomonas aeruginosa RuvA/RuvB protein complex helicase activity... 36155320
L02 IC50 = 400.0 nM 6.4 Cytotoxicity against human L02 cells assessed as inhibition of cell proliferatio... 39091011

Literature References

PubMed DOI Target Context # Activities
25675144 10.1021/jm5019302 HCT-8 29
29501947 10.1016/j.ejmech.2018.02.062 A549/TR 22
28994286 10.1021/acs.jmedchem.7b00971 Mus musculus 19
25675144 10.1021/jm5019302 Mus musculus 13
39091011 10.1021/acs.jmedchem.4c01160 ADMET 12
28994286 10.1021/acs.jmedchem.7b00971 Inhibitor of nuclear factor kappa-B kinase subunit beta 8
39091011 10.1021/acs.jmedchem.4c01160 BGC-823 8
29377691 10.1021/acs.jmedchem.7b01153 Rattus norvegicus 6
28994286 10.1021/acs.jmedchem.7b00971 Kelch-like ECH-associated protein 1 6
26908173 10.1021/acs.jmedchem.5b01292 Kelch-like ECH-associated protein 1 6
28994286 10.1021/acs.jmedchem.7b00971 Rattus norvegicus 6
36155320 10.1016/j.bmc.2022.117022 Unchecked 6
27031670 10.1021/acs.jmedchem.6b00228 Keap1/Nrf2 6
28994286 10.1021/acs.jmedchem.7b00971 Unchecked 5
25675144 10.1021/jm5019302 NON-PROTEIN TARGET 5
29377691 10.1021/acs.jmedchem.7b01153 Lung 5
30429953 10.1021/acsmedchemlett.8b00345 Unchecked 4
31682434 10.1021/acs.jmedchem.9b01074 Keap1/Nrf2 4
28994286 10.1021/acs.jmedchem.7b00971 Voltage-gated inwardly rectifying potassium channel KCNH2 2
28994286 10.1021/acs.jmedchem.7b00971 No relevant target 2

Data from ChEMBL 36 via Core Engine